foscarnet has been researched along with Hepatitis D in 2 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Excerpt | Relevance | Reference |
---|---|---|
"Foscarnet has been shown to inhibit the proliferation of human T and B lymphocytes in vitro." | 1.28 | Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? ( Hansson, BG; Nordenfelt, E; Riesbeck, K; Weiland, O, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansson, BG | 2 |
Riesbeck, K | 1 |
Nordenfelt, E | 2 |
Weiland, O | 2 |
Hedin, G | 1 |
Ljunggren, K | 1 |
Strömberg, A | 1 |
Oberg, B | 1 |
2 other studies available for foscarnet and Hepatitis D
Article | Year |
---|---|
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Cells, Cultured; DNA; Foscarnet; Hepatitis B; Hepatitis | 1991 |
Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Hepatitis B; Hepatitis D; Hum | 1987 |